This inventor holds 1 USPTO granted patent. Top assignee: Arius Research, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Mind of Kristian Rogers: Revolutionizing Cancer Treatment
Introduction: Inventor Kristian Rogers from Georgetown, CA, has made a significant impact in the field of cancer treatment with his groundbreaking patent.
Latest Patents: Kristian Rogers has one patent to his name, which focuses on the cytotoxicity mediation of cells evidencing surface expression of CD63. This invention plays a crucial role in diagnosing and treating various cancerous diseases, utilizing cancerous disease modifying antibodies (CDMAB) to initiate a cytotoxic response.
Career Highlights: Kristian Rogers is associated with Arius Research, Inc., a company at the forefront of cutting-edge research and development in the field of oncology. His work at Arius Research, Inc. showcases his dedication to advancing cancer treatment methodologies.
Collaborations: Throughout his career, Kristian has collaborated with esteemed professionals in the field, including coworkers David S F Young and Helen P Findlay. These collaborations have further fueled his innovative spirit and propelled the success of his inventions.
Conclusion: Kristian Rogers's passion for innovation and his contributions to the field of cancer treatment through his patented invention highlight his commitment to making a positive impact on the lives of many. His work serves as a beacon of hope for those navigating the challenges of cancer, offering new possibilities for diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile